This inventor holds 13 USPTO granted patents and 4 published patent applications. Top assignees: Handa Oncology, LLC, Handa Onocology, LLC, Handa Pharmaceuticals LLC. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saratoga, CA (US) (2018)
- San Jose, CA (US) (2021 - 2024)
Company Filing History:
11 out of 11 
1 out of 1 
1 out of 5 Years Active: 2018-2026
Title: Innovations and Contributions of Fang-Yu Liu in Pharmaceutical Patents
Introduction
Fang-Yu Liu, based in San Jose, California, has established himself as a prominent inventor in the pharmaceutical industry. With a remarkable portfolio of seven patents, Liu has made significant contributions, particularly in the development of kinase inhibitors.
Latest Patents
Among his latest inventions, Liu has developed notable patents such as "Kinase Inhibitor Salts and Compositions Thereof," which pertains to the cabozantinib lauryl sulfate salt and its methods of use. Additionally, he has worked on another patent titled "Kinase Inhibitor Salts and Compositions Thereof," focusing on capsules containing dasatinib lauryl sulfate salt. These advancements highlight Liu's expertise in creating innovative compounds for medical applications.
Career Highlights
Fang-Yu Liu has played a vital role in various organizations throughout his career. Notably, he has been associated with Handa Oncology, LLC, where his work has significantly impacted cancer therapeutics. His innovative approaches have contributed to the advancement of treatments for various forms of cancer.
Collaborations
Liu's collaborative spirit is evident in his partnerships with colleagues such as Chin-Yao Yang and Chi-Cheng Lin. Together, they have contributed to research and development projects that drive pharmaceutical innovation and enhance therapeutic options for patients.
Conclusion
Fang-Yu Liu's dedication to innovation in the pharmaceutical field, exemplified by his patents and collaborations, showcases his impact on medical research and development. His work with kinase inhibitors positions him as a significant inventor in the ongoing quest for effective cancer treatments. Liu's contributions are expected to continue influencing the industry, paving the way for new advancements in pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile